Make an inquiry
Refer a patient
We noticed you are on our US page. Want to switch regions? Choose from the options:
UK
AU
ES
Find a location
Find a doctor
Make an inquiry
Refer a patient
We noticed you are on our US page. Want to switch regions? Choose from the options:
UK
AU
ES
Find a location
Find a doctor
Make an inquiry
Refer a patient
Healthcare Professionals
Latest research
Publications
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
20 Jan 2018
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
Written by
Bloomston Mark, MD, FACS
, Mace TA, Shakya R, Pitarresi JR, Swanson B, McQuinn CW, Loftus S, Nordquist E, Cruz-Monserrate Z, Yu L, Young G, Zhong X, Zimmers TA, Ostrowski MC, Ludwig T, Bloomston M, Bekaii-Saab T, Lesinski GB
Back to top
